Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

09. Dezember 2025

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 2920


	Artikel 1 - 20 / 58399

	Anesthesia Type during Cancer Surgery: Results of the GA-CARES Randomized, Multicenter Trial. Anesthesiology Bennett-Guerrero E, Romeiser JL, DeMaria S, Nadler JW, Quinn TD, Ponnappan SK, Wang R, Gloff MS, Lee KJ, Levin MA, Sroka RD, Stanley SL, Wang D, Sasson AR, GA-CARES Trial Group. PMID: 41363871 [PubMed - indexed for MEDLINE]
	Incidental Diagnosis of Pancreatic Cancer and Association with Improved Patient Outcomes: Assessing the Potential Clinical Utility of Liquid Biopsy Based Screening Tests. J Am Coll Surg Javed AA, Habib JR, Fishman EK, Cameron JL, Hruban RH, Wolfgang CL, He J. PMID: 41363792 [PubMed - as supplied by publisher]
	Should transarterial chemoembolization be applied with systemic therapy for hepatocellular carcinoma with hepatic vein and/or inferior vena cava tumor thrombus (CHANCE2505)?: a multicenter study. Int J Surg Lin LW, Chen Q, Hu HT, Zhou GH, Jin ZC, Zhou Y, Chen JJ, Ji JS, Zhu XL, Huang M, Shi HB, Yang WZ, Xu GH, Xu AB, Hu ZC, Wang WD, Zhao C, Zhu HD. PMID: 41363180 [PubMed - as supplied by publisher]
	Bone Marrow Metastasis from a Pancreatic Neuroendocrine Tumor: Morphologic Mimicry of Acute Leukemia. Clin Lab Lian X, Li H, Li S, Xu L, Zhang S, Li H, Li R. PMID: 41362202 [PubMed - indexed for MEDLINE]
	Adjuvant benmelstobart plus anlotinib in patients with high-risk recurrence after resection of hepatocellular carcinoma: a phase II study (ALTER-H006). Nat Commun Duan X, Wu D, Zhou C, Tian Y, Duan W, Chen B, Shen J, Xu G, Bai Y, Mao X. PMID: 41361175 [PubMed - as supplied by publisher]
	Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-analysis. Ann Intern Med Ko A, Chang YC, Bahar F, Wang TH, Xanthavanij N, Yu CC, Hsieh RJ, See XY, Lo SW, Song J, Hsia YP, Chiang CH, Xu X, Lin S, Chiang CH. PMID: 41359966 [PubMed - as supplied by publisher]
	Nimotuzumab Plus Gemcitabine-based Adjuvant Chemotherapy for Resectable Pancreatic Cancer: A Retrospective Observational Study. Pancreas Zou S, Wen C, Li F, Jiang L, Tian Q, Chen H, Deng X, Peng C, Shen B, Zhan Q. PMID: 41359420 [PubMed - as supplied by publisher]
	Spleen Preservation in Solid Pseudopapillary Neoplasms: Evidence, Rationale, and Practical Considerations. Am Surg Lenzi MC, Carvalho MCAP, Rocha GFS, Juca RH, De Oliveira Filho M, Souza DLS, Fernandes MM, Santana AUL, Camarotti TAF, Portugal MM, De Mello EB. PMID: 41359292 [PubMed - as supplied by publisher]
	Palliative care in pancreatic cancer: effects on symptom burden, survival, and place of death. Support Care Cancer Allende-Pérez S, Melchor-Ruan J, Cruz-Sánchez JJ, Martínez-Barrios I, Peña-Nieves A, Herrera-Guerrero MI, Ruiz-Garcia E, Cabrera-Galeana PA. PMID: 41359199 [PubMed - indexed for MEDLINE]
	Unusual complications following endoscopic ultrasound-guided hepaticogastrostomy: A call for refined techniques and dedicated devices. World J Gastroenterol Choi JH, Paik WH. PMID: 41358179 [PubMed - indexed for MEDLINE]
	Cystic tumors of the pancreas: Current perspectives on diagnosis and management. World J Gastroenterol Shumka N, Karagyozov PI. PMID: 41358177 [PubMed - indexed for MEDLINE]
	Pancreatic cancer in 2025: Have we found a solution? World J Gastroenterol Tonini V, Zanni M. PMID: 41358172 [PubMed - indexed for MEDLINE]
	Preoperative malignancy risk assessment in pancreatic cystic neoplasms using clinical and laboratory parameters. World J Gastrointest Surg Martli HF, Acehan F, , , Sürel AA, Er S, Tez M. PMID: 41357639 [PubMed]
	Clinicopathological features of patients undergoing surgery for pancreatic cancer with very early postoperative recurrence. World J Gastrointest Surg Martl, , Alta, Eri, Çayhan V, Ersoy O, Ke, Tez M. PMID: 41357630 [PubMed]
	Regular use of pharmaceutical opioids and subsequent risk of cancer: a prospective cohort study and Mendelian randomization analysis. EClinicalMedicine Sheikh M, Domingues A, Alcala K, Langdon R, Mariosa D, Feng X, Sarich P, Weber MF, Viallon V, Fournier A, Kamangar F, Malekzadeh R, Gillette C, Vitolins MZ, Adams MCB, Virani S, Ebrahimi E, Dudding T, Galesloot TE, Kiemeney LA, Rothman N, Koutros S, Zhou J, Pearson SA, Parat MO, Brennan P, Johansson M, Davey Smith G, Robbins HA. PMID: 41357337 [PubMed]
	Can Symptom Clusters Predict Stage, Resectability, and Survival in Pancreatic Cancer? Cancer Manag Res Demir MS, A. PMID: 41356429 [PubMed]
	KRT17: A Key Driver of Cancer Therapy Resistance and Emerging Therapeutic Target. Cancer Manag Res Hou W. PMID: 41356425 [PubMed]
	The Burden of Pancreatic Cancer in Five East Asian Countries From 1990 to 2021 and Its Prediction up to 2036: A Systemic Analysis of the Global Burden of Diseases Study 2021. Cancer Med Guo T, Zhu W, Hui Y, Wang Y, Zhou T, Shen W, Li L, Yang Y, Cheng H. PMID: 41355376 [PubMed - indexed for MEDLINE]
	Integrated ultrasound radiomics and clinical data to predict PD-1 blockade efficacy in unresectable hepatocellular carcinoma. BMC Gastroenterol Jiang D, Liu Z, Wang K, Qian Y, Feng J, Gong L, Ren J, Xiang Y, Zhang F, Liu L, Zhou H, Liang C, Wei W, Zang B, Kong C, Li Y, Cheng S. PMID: 41354910 [PubMed - as supplied by publisher]
	Adaptive Drug Resistance Mechanisms Driven by Non-coding RNA-Protein Interaction Networks in Hepatocellular Carcinoma. Crit Rev Oncol Hematol Tian Y, Ouyang K, Wu H, Liao H, He L, Luo T, Ma K, Mao X, Wang F, Xiong H. PMID: 41354412 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 58399

Seite 1 von 2920



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung